Early-career interventional cardiologists in the US care for pts w/ a more acute presentation & higher predicted risk of mortality & bleeding vs pts treated by their more experienced colleagues, w/ modestly worse outcomes. https://t.co/2JDrZwM2pK
(1/2) #JACC #NCDR #ACCEarlyCareer
"Dovrei prenotare una risonanza magnetica"
"Mi dispiace, le agende di prenotazione sono chiuse"
Bene sapere che la chiusura delle agende di prenotazione è vietata dalla L. 266/2005, con tanto di sanzioni amministrative per i trasgressori
RT 🙏
#SalviamoSSN
Gratitudine eterna a medici, infermieri e tutti i professionisti sanitari.
Ma basta con la retorica degli eroi: la politica allinei retribuzioni e condizioni di lavoro agli standard europei.
Altrimenti sarà la morte del Servizio Sanitario Nazionale
#SalviamoSSN#20febbraio
@LAzzaliniMD@UWCathLab nice case!
Is it possible that the green curve is higher than the red one in the final rfr measurement?
how do you explain this?
@LAzzaliniMD
La perdita della #sanità pubblica non viene annunciata dal fragore di una valanga, ma dal silenzioso scivolamento di un ghiacciaio.
Che lentamente, ma inesorabilmente, erode il diritto costituzionale alla tutela della salute
#SalviamoSSN
The antiplatelet pretreatment recommendation is one of the most volatile I can think of in the guidelines for acute coronary syndromes. Each task force, essentially based on the same limited data available, has given significantly different interpretations over time. #CRT2022
TARGET-FFR:over 2/3 of patients had a physiologically suboptimal result after angiography-guided PCI.FFR-guided optimization strategy did not significantly increase the proportion of patients with a final FFR≥0.90,but did reduce the proportion of patients with a final FFR≤0.80.
Since its introduction almost two decades ago, the crush technique for coronary bifurcation stenting has undergone a significant and constant evolution. This paper reviews the technical aspects and outcomes of the variants of the crush technique.
https://t.co/Is6mNeHpxA
De-escalation of antithrombotic potency after PCI is a strategy meant to reduce the risk of bleeding, which consists of 3 options: discontinuation of an antiplatelet agent, unguided or guided switch, dose reduction. These strategies have never been compared head-to-head. #TCT2021